Establishment of a Longitudinal Cohort for Newborns With Low Apgar Scores at Birth

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Apr 29, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on understanding and improving care for newborns with low Apgar scores. The Apgar score is a quick test done at one, five, and sometimes ten minutes after birth to check a baby's health. A low score (7 or below) can indicate that a baby may need special care or help with breathing. The goal of the study is to identify risk factors for low scores, improve resuscitation techniques, and provide ongoing support and interventions for these newborns. By gathering this information, the researchers hope to enhance the care provided to these infants and improve their long-term health outcomes.

To be eligible for the study, newborns must have been born at Peking University Third Hospital with an Apgar score of 7 or below. This includes babies born from January 1, 2006, until the project starts, as well as those born until December 31, 2027. However, if a baby has serious congenital anomalies or if the family does not wish to participate, they will not be included in the study. Participants can expect to receive follow-up care and guidance based on their needs, which aims to help improve their health over time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Retrospective cohort inclusion criteria: Newborns born between January 1, 2006 and before the start of the project at Peking University Third Hospital with Apgar scores ≤ 7 at 1 minute, 5 minutes, or 10 minutes.
• • Prospective cohort inclusion criteria: Newborns born at Peking University Third Hospital between the start of the project and December 31, 2027, with an Apgar score of ≤ 7 at 1 minute, 5 minutes, or 10 minutes.
• Exclusion Criteria:
• • There are serious congenital malformations that affect physical and neurological development, and family members refuse to participate in the study